ERD

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Can we use interleukin-1β blockade for lung cancer treatment?

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Cancer Stem Cells and Targeting Strategies

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

One manuscript on new formulations of antibodies to activate immune cells submitted for publication

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

One manuscript on the combination of antibodies with T cells submitted for publication

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodg...

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Cancer cells induce interleukin-22 production from memory CD4 + T cells via interleukin-1 to promote tumor growth

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

One manuscript on the combination of antibodies with therapeutic nucleic acids submitted for publication

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

One manuscript on the combination of antibodies with dendritic cell therapy submitted for publication

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Periodic Reporting for period 2 - IMMUTRAIN (Training Network for the Immunotherapy of Cancer)

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

supervisory board

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Potent Metabolic Sialylation Inhibitors Based on C-5-Modified Fluorinated Sialic Acids

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Sialic acid blockade suppresses tumor growth by enhancing T cell-mediated tumor immunity

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

A TLR7 agonist strengthens T and NK cell function during BRAF‐targeted therapy in a preclinical melanoma model

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasi...

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

MERTK Acts as a Costimulatory Receptor on Human CD8 + T Cells

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

P329G-CAR-J: a novel Jurkat-NFAT-based CAR-T reporter system recognizing the P329G Fc mutation

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Reports on conferences on the homepage

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

IMMUTRAIN position paper

Project: IMMUTRAIN

Updated at: 28-04-2024

Show more information

Project acronym IMMUTRAIN

Resources

Selected filters:

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy

Can we use interleukin-1β blockade for lung cancer treatment?

Cancer Stem Cells and Targeting Strategies

One manuscript on new formulations of antibodies to activate immune cells submitted for publication

One manuscript on the combination of antibodies with T cells submitted for publication

PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodg...

Cancer cells induce interleukin-22 production from memory CD4 + T cells via interleukin-1 to promote tumor growth

MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine

One manuscript on the combination of antibodies with therapeutic nucleic acids submitted for publication

One manuscript on the combination of antibodies with dendritic cell therapy submitted for publication

Periodic Reporting for period 2 - IMMUTRAIN (Training Network for the Immunotherapy of Cancer)

supervisory board

Potent Metabolic Sialylation Inhibitors Based on C-5-Modified Fluorinated Sialic Acids

Sialic acid blockade suppresses tumor growth by enhancing T cell-mediated tumor immunity

Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer

A TLR7 agonist strengthens T and NK cell function during BRAF‐targeted therapy in a preclinical melanoma model

Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasi...

Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy

MERTK Acts as a Costimulatory Receptor on Human CD8 + T Cells

P329G-CAR-J: a novel Jurkat-NFAT-based CAR-T reporter system recognizing the P329G Fc mutation

Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy

RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade

Reports on conferences on the homepage

IMMUTRAIN position paper